Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells

Human cytomegalovirus (HCMV) is a leading cause of permanent birth defects, highlighting the need to develop an HCMV vaccine candidate. However, HCMV vaccine development is complicated by the varying capacity of neutralizing antibodies (NAb) to interfere in vitro with the HCMV entry routes mediating...

Descripción completa

Detalles Bibliográficos
Autores principales: Wussow, Felix, Chiuppesi, Flavia, Contreras, Heidi, Diamond, Don J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748606/
https://www.ncbi.nlm.nih.gov/pubmed/29088098
http://dx.doi.org/10.3390/vaccines5040039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748606/
https://www.ncbi.nlm.nih.gov/pubmed/29088098
http://dx.doi.org/10.3390/vaccines5040039

Ejemplares similares